rs553265417
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 8P and 12B. PVS1BP6_Very_StrongBS2
The NM_203288.2(RP9):c.664delT(p.Ter222AspfsTer29) variant causes a frameshift, stop lost change. The variant allele was found at a frequency of 0.0076 in 152,304 control chromosomes in the GnomAD database, including 10 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 10 hom., cov: 32)
Exomes 𝑓: 0.011 ( 103 hom. )
Failed GnomAD Quality Control
Consequence
RP9
NM_203288.2 frameshift, stop_lost
NM_203288.2 frameshift, stop_lost
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.31
Publications
5 publications found
Genes affected
RP9 (HGNC:10288): (RP9 pre-mRNA splicing factor) The protein encoded by this gene can be bound and phosphorylated by the protooncogene PIM1 product, a serine/threonine protein kinase . This protein localizes in nuclear speckles containing the splicing factors, and has a role in pre-mRNA splicing. CBF1-interacting protein (CIR), a corepressor of CBF1, can also bind to this protein and effects alternative splicing. Mutations in this gene result in autosomal dominant retinitis pigmentosa-9. This gene has a pseudogene (GeneID: 441212), which is located in tandem array approximately 166 kb distal to this gene. [provided by RefSeq, Sep 2009]
RP9 Gene-Disease associations (from GenCC):
- retinitis pigmentosa 9Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PVS1
Stoplost variant. No alternative stopcodon identified downstream, so we assume a Nonstop Mediated Decay. LoF is a known mechanism of disease.
BP6
Variant 7-33095235-CA-C is Benign according to our data. Variant chr7-33095235-CA-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1158 AD,Unknown gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RP9 | NM_203288.2 | c.664delT | p.Ter222AspfsTer29 | frameshift_variant, stop_lost | Exon 6 of 6 | ENST00000297157.8 | NP_976033.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RP9 | ENST00000297157.8 | c.664delT | p.Ter222AspfsTer29 | frameshift_variant, stop_lost | Exon 6 of 6 | 1 | NM_203288.2 | ENSP00000297157.3 |
Frequencies
GnomAD3 genomes AF: 0.00762 AC: 1160AN: 152186Hom.: 10 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1160
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00753 AC: 1857AN: 246492 AF XY: 0.00753 show subpopulations
GnomAD2 exomes
AF:
AC:
1857
AN:
246492
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0110 AC: 16044AN: 1452128Hom.: 103 Cov.: 28 AF XY: 0.0108 AC XY: 7844AN XY: 723066 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
16044
AN:
1452128
Hom.:
Cov.:
28
AF XY:
AC XY:
7844
AN XY:
723066
show subpopulations
African (AFR)
AF:
AC:
55
AN:
33284
American (AMR)
AF:
AC:
138
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
AC:
238
AN:
26060
East Asian (EAS)
AF:
AC:
1
AN:
39628
South Asian (SAS)
AF:
AC:
728
AN:
85900
European-Finnish (FIN)
AF:
AC:
401
AN:
53408
Middle Eastern (MID)
AF:
AC:
28
AN:
5744
European-Non Finnish (NFE)
AF:
AC:
13891
AN:
1103392
Other (OTH)
AF:
AC:
564
AN:
60038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
697
1394
2092
2789
3486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00760 AC: 1158AN: 152304Hom.: 10 Cov.: 32 AF XY: 0.00720 AC XY: 536AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
1158
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
536
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
85
AN:
41568
American (AMR)
AF:
AC:
81
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
37
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5192
South Asian (SAS)
AF:
AC:
27
AN:
4824
European-Finnish (FIN)
AF:
AC:
91
AN:
10616
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
820
AN:
68022
Other (OTH)
AF:
AC:
13
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
56
112
168
224
280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
RP9: PM4, BS1, BS2
May 18, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
May 05, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Retinal dystrophy Benign:1
Jan 01, 2013
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Retinitis Pigmentosa, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Retinitis pigmentosa 9 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.